Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06557434 · ClinicalTrials.gov registry record · NA
AV-23-001 AVAVA MIRIA Pilot Study
A NA study of Wrinkle and Skin Laxity, sponsored by AVAVA.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT06557434: Active NA study of Wrinkle and Skin Laxity, sponsored by AVAVA.
NCT06557434 is a NA study of Wrinkle and Skin Laxity that is active but no longer recruiting, run by AVAVA. The registered enrollment target is 200 participants, above the 112-participant average among 25 other Wrinkle trials with a reported enrollment target (79% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06557434, a NA study of Wrinkle and Skin Laxity, is active but no longer recruiting, sponsored by AVAVA.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
This non-significant risk study is intended to demonstrate the use of the MIRIA Skin Treatment System can show improvement in dermatologic conditions currently indicated for treatment with a laser (such as, but not limited to, benign pigmented lesions, benign cutaneous lesions, wrinkles, textural irregularities, or scars). The study is also intended to assist in determination of the optimal laser configuration and treatment parameters that most consistently yield results.
Primary Outcome
Scale used to compare before and after images of subjects treated. Scores include the following: 1. \- Very Much Improved 2. \- Much Improved 3. \- Improved 4. \- No Change 5. \- Worse
Conditions Studied
Interventions
- DEVICE MIRIA
Study Locations (2)
New York
- Skinfluence Long Island - Dix Hills
- Laser and Skin Surgery Center of New York - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-11-06 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT06557434 still lists
NCT06557434 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 112-participant average among 25 other Wrinkle trials with a reported enrollment target (79% higher).
The record links to 5 conditions, with Wrinkle appearing as the primary indexed condition, and to 1 intervention - of which MIRIA is the first listed.
NCT06557434 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06557434 about?
NCT06557434 is a clinical study titled "AV-23-001 AVAVA MIRIA Pilot Study". This non-significant risk study is intended to demonstrate the use of the MIRIA Skin Treatment System can show improvement in dermatologic conditions currently indicated for treatment with a laser (such as, but not limited to, benign pigmented lesions, benign cutaneous lesions, wrinkles, textural ir...
What is the current status of trial NCT06557434?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-11-06. Estimated completion is 2026-12-31.
What conditions does trial NCT06557434 study?
This clinical trial studies the following conditions: Wrinkle, Skin Laxity, Acne Scars - Mixed Atrophic and Hypertrophic, Scars, Pigmented Lesions.
What interventions are being tested in trial NCT06557434?
The interventions under investigation include: MIRIA (DEVICE).
Who is sponsoring clinical trial NCT06557434?
This trial is sponsored by AVAVA, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06557434 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06557434's enrollment target sits among peer trials
200 4th of 25 higher than 21 of 25 other Wrinkle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wrinkle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
RECRUITING · NA
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
RECRUITING · NA
-
The Effects of Almond on Facial Skin Collagen and Wrinkles
RECRUITING · NA
-
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI